On May 21st, the 92nd China International Pharmaceutical Raw Materials/Intermediates/Packaging/Equipment Trade Fair (API China), a three-day event, officially opened at the Guangzhou International Convention and Exhibition Center. As a highly authoritative professional exhibition in the pharmaceutical industry, this year's event brought together over 3,000 leading pharmaceutical companies, research institutions, and supply chain service providers from around the world, covering the entire industry chain from API production and formulation processing to medical device manufacturing. It is expected to attract over 200,000 visitors. Feili Electric showcased its Medical Device Sterilizer series of pharmaceutical-grade ozone equipment, becoming a core focus of the exhibition and winning high praise from both domestic and international customers thanks to its over 14 years of experience in the ozone field, its comprehensive solutions, and its one-stop service capabilities.
At the exhibition, the Feili booth saw a constant flow of visitors, with a lively atmosphere of consultation and negotiation. Representatives from pharmaceutical companies across China, as well as Europe, South America, Southeast Asia, and North America, engaged in in-depth discussions with the Feili technical team regarding core needs such as disinfection of pharmaceutical cleanrooms, sterilization of medical devices, purification of production water, and aseptic treatment of packaging materials. Many long-term clients made a special trip to visit, sharing the stable performance of Feili equipment in actual production. An executive from a large pharmaceutical company mentioned that after using Feili's Clean Room Ozone Generator in their Class A cleanroom, the airborne bacteria index has been consistently controlled at ≤1 CFU/m³, all settling bacteria tests have met standards, and the company has successfully passed GMP certification annual inspections for three consecutive years. The equipment operates continuously 24 hours a day without failure, significantly reducing maintenance costs. A representative from a Southeast Asian pharmaceutical company stated that Feili's comprehensive international certifications (CE, FCC, RoHS) and its customization capabilities to adapt to overseas voltage standards have ensured smooth acceptance of their export projects. Their participation in the meeting was specifically to finalize cooperation on ozone disinfection for their new production line.
As a national high-tech enterprise integrating design, R&D, production, and sales, Feili's core competitiveness was fully demonstrated at the exhibition: With over 14 years of focus on ozone generators, it has accumulated over 40 patented technologies. Its core components utilize titanium-modified quartz discharge tubes, combined with micro-gap discharge technology, achieving ozone output accuracy of ±5% and a sterilization efficiency of over 99.9%, perfectly meeting the stringent requirements of the pharmaceutical industry for high cleanliness, residue-free operation, and high stability. From laboratory pilot-scale and pilot-scale production to large-scale production, Feili can provide complete solutions, encompassing a "one-stop" service including pre-production technical consultation, customized solution design, equipment selection and matching, on-site installation and commissioning, and post-production operation, maintenance, and technology upgrades, precisely matching the full-scenario disinfection needs of pharmaceutical companies from R&D to mass production.
Addressing the pain points of the pharmaceutical industry, Feili's Pharmaceutical Ozone Sterilizers series demonstrates strong adaptability to various scenarios: For cleanrooms, the equipment can be integrated with air conditioning and ventilation systems to achieve air circulation disinfection, eliminating blind spots, and the ozone quickly reverts to oxygen after reaction, leaving no chemical residue and not affecting drug components or the production environment; for medical devices, when paired with a high-concentration ozone water generation system, it can thoroughly sterilize devices that are not resistant to high temperatures and pressures, avoiding the risk of chemical disinfectant residues; for production water and packaging materials, the Ozone Air Purifier for Pharmaceuticals dedicated process effectively kills pathogens in water, decomposes organic impurities, and simultaneously achieves aseptic treatment of packaging material surfaces, comprehensively helping pharmaceutical companies improve product safety and compliance.
Currently, Feili's customers are located throughout China and many regions globally, covering various pharmaceutical sub-sectors such as API production, formulation processing, medical device manufacturing, and biopharmaceuticals. With stable product performance, professional technical support, and efficient after-sales service, Feili has accumulated a good reputation in the industry. This exhibition is not only a concentrated display of Feili's technology and products, but also an important opportunity to deeply connect with global pharmaceutical industry partners and explore industry development trends. In the future, Feili will continue to uphold its core values of "focus, excellence, sincerity, responsibility, and altruism," continuously deepen its research and development of pharmaceutical-grade ozone disinfection technology, optimize its product and service system, and provide the global pharmaceutical industry with more efficient, safe, and compliant cleanroom solutions.
